JIRONG LU,JULIAN DAVIES,LING LIU,MARK ANDREW WORTINGER,PETER EDWARD VAILLANCOURT,WEI ZENG
申请号：
BRPI0922800
公开号：
BRPI0922800A2
申请日:
2009.11.18
申请国别(地区):
BR
年份:
2015
代理人:
摘要：
Provided are monoclonal antibodies, antigen-binding fragments thereof, and combinations of the foregoing, that bind to, and inhibit the activity of, c-Met, and that are effective in treating cancers and other diseases, disorders, or conditions where pathogenesis is mediated by c-Met.
